Clearside Biomedical Inc (CLSD)
1.32
+0.01
(+0.76%)
USD |
NASDAQ |
May 17, 16:00
1.32
0.00 (0.00%)
After-Hours: 20:00
Clearside Biomedical Total Long Term Debt (Quarterly): 0.00 for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.991M |
September 30, 2020 | 0.991M |
June 30, 2020 | 0.991M |
March 31, 2020 | 5.183M |
Date | Value |
---|---|
December 31, 2019 | 5.152M |
September 30, 2019 | 10.16M |
June 30, 2019 | 10.10M |
March 31, 2019 | 10.04M |
December 31, 2018 | 9.975M |
September 30, 2018 | 9.911M |
June 30, 2018 | 9.848M |
March 31, 2018 | 7.307M |
December 31, 2017 | 8.009M |
September 30, 2017 | 7.903M |
June 30, 2017 | 7.796M |
March 31, 2017 | 7.691M |
December 31, 2016 | 7.586M |
September 30, 2016 | 7.489M |
June 30, 2016 | 5.686M |
March 31, 2016 | 6.035M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2021
10.16M
Maximum
Sep 2019
1.678M
Average
--
Median
Mar 2021
Total Long Term Debt (Quarterly) Benchmarks
Cassava Sciences Inc | -- |
Heron Therapeutics Inc | 173.99M |
Actinium Pharmaceuticals Inc | -- |
Karyopharm Therapeutics Inc | 171.13M |
Ocular Therapeutix Inc | 66.46M |